Earnings Feed
Start Free
Home/Filings/4/0001127602-23-012216
4//SEC Filing

Clark James David 4

Accession 0001127602-23-012216

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:26 PM ET

Size

18.3 KB

Accession

0001127602-23-012216

Insider Transaction Report

Form 4
Period: 2023-04-01
CVS HEALTH CorpCVS
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
  • Award

    Stock Option

    2023-04-01$74.31/sh+9,649$717,017→ 9,649 total
    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (9,649 underlying)
  • Tax Payment

    Common Stock

    2023-04-01$74.31/sh−1,471$109,310→ 30,457.255 total
  • Award

    Common Stock (Restricted)

    2023-04-01$74.31/sh+2,186$162,442→ 9,080 total
Holdings

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (7,044 underlying)
    7,044

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (17,157 underlying)
    17,157

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (7,513 underlying)
    7,513

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (9,050 underlying)
    9,050

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (12,094 underlying)
    12,094

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (24,240 underlying)
    24,240

  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (6,756 underlying)
    6,756
Footnotes (11)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
  • [F10]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
  • [F2]Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2024.
  • [F3]Options became exercisable in four equal annual installments beginning on 4/1/2017.
  • [F4]Options became exercisable in four equal annual installments beginning on 4/3/2018.
  • [F5]Options became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F6]Options became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001757584

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:26 PM ET
Size
18.3 KB
View on SEC.gov